Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 36

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

CXCR4+CD45− BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in mice

Wang, Jianping, Liu, Xi, Lu, Hong, Jiang, Chao, Cui, Xiaobing, Yu, Lie, Fu, Xiaojie, Li, Qian, Wang, Jian·2015·Brain, Behavior, and Immunity

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbi.2014.12.015

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 69

  1. Abdullah, 2014, NADPH oxidase mediates TNF-alpha-evoked in vitro brain barrier dysfunction: roles of apoptosis and time, Mol. Cell. Neurosci., 61, 72, 10.1016/j.mcn.2014.06.002 · DOI
  2. Arnous, 2012, Bone marrow mononuclear cells and acute myocardial infarction, Stem Cell Res. Ther., 3, 2, 10.1186/scrt93 · DOI
  3. Azizi, 1998, Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats–similarities to astrocyte grafts, Proc. Natl. Acad. Sci. U.S.A., 95, 3908, 10.1073/pnas.95.7.3908 · DOI · Paper page
  4. Bliss, 2010, Optimizing the success of cell transplantation therapy for stroke, Neurobiol. Dis., 37, 275, 10.1016/j.nbd.2009.10.003 · DOI · Paper page
  5. Boltze, 2011, Histopathological investigation of different MCAO modalities and impact of autologous bone marrow mononuclear cell administration in an ovine stroke model, Transl. Stroke Res., 2, 279, 10.1007/s12975-011-0101-5 · DOI
  6. Borlongan, 2011, The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders, Prog. Neurobiol., 95, 213, 10.1016/j.pneurobio.2011.08.005 · DOI · Paper page
  7. Brenneman, 2010, Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats, J. Cereb. Blood Flow Metab., 30, 140, 10.1038/jcbfm.2009.198 · DOI · Paper page
  8. Burns, 2011, Stem cells and stroke: opportunities, challenges and strategies, Expert Opin. Biol. Ther., 11, 447, 10.1517/14712598.2011.552883 · DOI
  9. Caplan, 2006, Mesenchymal stem cells as trophic mediators, J. Cell. Biochem., 98, 1076, 10.1002/jcb.20886 · DOI · Paper page
  10. Chen, 2005, Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice, J. Neurosci., 25, 2366, 10.1523/JNEUROSCI.5071-04.2005 · DOI · Paper page
  11. Chen, 2003, Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats, Circ. Res., 92, 692, 10.1161/01.RES.0000063425.51108.8D · DOI · Paper page
  12. Civin, 1993, Antigenic analysis of hematopoiesis: a review, J. Hematother., 2, 137, 10.1089/scd.1.1993.2.137 · doi:10.1089/scd.1.1993.2.137
  13. Crosby, 2000, Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation, Circ. Res., 87, 728, 10.1161/01.RES.87.9.728 · DOI · Paper page
  14. Cui, 2013, The neurorestorative benefit of GW3965 treatment of stroke in mice, Stroke, 44, 153, 10.1161/STROKEAHA.112.677682 · DOI
  15. Dominici, 2006, Minimal criteria for defining multipotent mesenchymal stromal cells, Cytotherapy, 8, 315, 10.1080/14653240600855905 · DOI · Paper page
  16. Duenas, 2014, Hepatogenic and neurogenic differentiation of bone marrow mesenchymal stem cells from abattoir-derived bovine fetuses, BMC Vet. Res., 10, 154, 10.1186/1746-6148-10-154 · doi:10.1186/1746-6148-10-154
  17. Eglitis, 1997, Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice, Proc. Natl. Acad. Sci. U.S.A., 94, 4080, 10.1073/pnas.94.8.4080 · DOI · Paper page
  18. Faulkner, 2004, Reactive astrocytes protect tissue and preserve function after spinal cord injury, J. Neurosci., 24, 2143, 10.1523/JNEUROSCI.3547-03.2004 · DOI · Paper page
  19. Fujita, 2010, Early protective effect of bone marrow mononuclear cells against ischemic white matter damage through augmentation of cerebral blood flow, Stroke, 41, 2938, 10.1161/STROKEAHA.110.596379 · DOI
  20. Fukuda, 2005, Mesenchymal, but not hematopoietic, stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction in mice, Kidney Int., 68, 1940, 10.1111/j.1523-1755.2005.00624.x · DOI
  21. Hess, 2004, Hematopoietic origin of microglial and perivascular cells in brain, Exp. Neurol., 186, 134, 10.1016/j.expneurol.2003.11.005 · DOI · Paper page
  22. Hess, 2011, Cell therapy for ischaemic stroke, Cell Prolif., 44, 1, 10.1111/j.1365-2184.2010.00718.x · DOI
  23. Hill, 2004, SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury, J. Neuropathol. Exp. Neurol., 63, 84, 10.1093/jnen/63.1.84 · DOI · Paper page
  24. Hochedlinger, 2003, Nuclear transplantation, embryonic stem cells, and the potential for cell therapy, N. Engl. J. Med., 349, 275, 10.1056/NEJMra035397 · DOI · Paper page
  25. Iihoshi, 2004, A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats, Brain Res., 1007, 1, 10.1016/j.brainres.2003.09.084 · DOI · Paper page
  26. Jaenisch, 2002, Nuclear cloning, embryonic stem cells, and transplantation therapy, Harvey Lect., 98, 145
  27. Jang, 2004, Hematopoietic stem cells convert into liver cells within days without fusion, Nat. Cell Biol., 6, 532, 10.1038/ncb1132 · DOI · Paper page
  28. Jiang, 2013, Comparison of the therapeutic effects of bone marrow mononuclear cells and microglia for permanent cerebral ischemia, Behav. Brain Res., 250, 222, 10.1016/j.bbr.2013.05.011 · DOI
  29. Krause, 2001, Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell, Cell, 105, 369, 10.1016/S0092-8674(01)00328-2 · DOI · Paper page
  30. Kucia, 2005, Bone marrow as a source of circulating CXCR4+ tissue-committed stem cells, Biol. Cell, 97, 133, 10.1042/BC20040069 · DOI · Paper page
  31. Kucia, 2004, Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury, Blood Cells Mol. Dis., 32, 52, 10.1016/j.bcmd.2003.09.025 · DOI · Paper page
  32. Kucia, 2006, A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow, Leukemia, 20, 857, 10.1038/sj.leu.2404171 · DOI · Paper page
  33. Kucia, 2007, Adult marrow-derived very small embryonic-like stem cells and tissue engineering, Expert Opin. Biol. Ther., 7, 1499, 10.1517/14712598.7.10.1499 · DOI
  34. Liu, 2014, Cell based therapies for ischemic stroke: from basic science to bedside, Prog. Neurobiol., 115, 92, 10.1016/j.pneurobio.2013.11.007 · DOI · Paper page
  35. Liu, 2014, Beneficial effects of gfap/vimentin reactive astrocytes for axonal remodeling and motor behavioral recovery in mice after stroke, Glia, 62, 2022, 10.1002/glia.22723 · DOI · Paper page
  36. Longa, 1989, Reversible middle cerebral artery occlusion without craniectomy in rats, Stroke, 20, 84, 10.1161/01.STR.20.1.84 · DOI · Paper page
  37. Malliaras, 2011, Cardiac cell therapy: where we’ve been, where we are, and where we should be headed, Br. Med. Bull., 98, 161, 10.1093/bmb/ldr018 · DOI · Paper page
  38. Mendez-Otero, 2007, Potential roles of bone marrow stem cells in stroke therapy, Regen. Med., 2, 417, 10.2217/17460751.2.4.417 · DOI
  39. Mezey, 2000, Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow, Science, 290, 1779, 10.1126/science.290.5497.1779 · DOI · Paper page
  40. Misra, 2012, Stem cell therapy in ischemic stroke: role of IV and intra-arterial therapy, Neurology, 79, S207, 10.1212/WNL.0b013e31826959d2 · DOI
  41. Murry, 2004, Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts, Nature, 428, 664, 10.1038/nature02446 · DOI · Paper page
  42. Nor, 1999, Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression, Am. J. Pathol., 154, 375, 10.1016/S0002-9440(10)65284-4 · DOI · Paper page
  43. Orlic, 2003, Bone marrow stem cells regenerate infarcted myocardium, Pediatr. Transplant., 7, 86, 10.1034/j.1399-3046.7.s3.13.x · DOI · Paper page
  44. Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143 · DOI · Paper page
  45. Prasad, 2012, Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: a pilot study, Indian J. Med. Res., 136, 221
  46. Prockop, 1997, Marrow stromal cells as stem cells for nonhematopoietic tissues, Science, 276, 71, 10.1126/science.276.5309.71 · DOI · Paper page
  47. Ratajczak, 2011, Higher number of stem cells in the bone marrow of circulating low Igf-1 level Laron dwarf mice–novel view on Igf-1, stem cells and aging, Leukemia, 25, 729, 10.1038/leu.2010.314 · DOI
  48. Ratajczak, 2004, Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells ‘hide out’ in the bone marrow, Leukemia, 18, 29, 10.1038/sj.leu.2403184 · DOI · Paper page
  49. Ratajczak, 2007, A hypothesis for an embryonic origin of pluripotent Oct-4(+) stem cells in adult bone marrow and other tissues, Leukemia, 21, 860, 10.1038/sj.leu.2404630 · DOI · Paper page
  50. Savitz, 2013, Cell therapies: careful translation from animals to patients, Stroke, 44, S107, 10.1161/STROKEAHA.112.679605 · DOI
  51. Schaar, 2010, Functional assessments in the rodent stroke model, Exp. Transl. Stroke Med., 2, 13, 10.1186/2040-7378-2-13 · DOI · Paper page
  52. Schwarting, 2008, Hematopoietic stem cells reduce postischemic inflammation and ameliorate ischemic brain injury, Stroke, 39, 2867, 10.1161/STROKEAHA.108.513978 · DOI
  53. Seeger, 2009, CXCR4 expression determines functional activity of bone marrow-derived mononuclear cells for therapeutic neovascularization in acute ischemia, Arterioscler. Thromb. Vasc. Biol., 29, 1802, 10.1161/ATVBAHA.109.194688 · DOI
  54. Sharma, 2010, Bone marrow mononuclear cells protect neurons and modulate microglia in cell culture models of ischemic stroke, J. Neurosci. Res., 88, 2869, 10.1002/jnr.22452 · DOI
  55. Shichinohe, 2010, Bone marrow stromal cells and bone marrow-derived mononuclear cells: which are suitable as cell source of transplantation for mice infarct brain?, Neuropathology, 30, 113, 10.1111/j.1440-1789.2009.01050.x · DOI
  56. Shichinohe, 2007, Role of SDF-1/CXCR4 system in survival and migration of bone marrow stromal cells after transplantation into mice cerebral infarct, Brain Res., 1183, 138, 10.1016/j.brainres.2007.08.091 · DOI
  57. Taguchi, 2009, Circulating CD34-positive cells have prognostic value for neurologic function in patients with past cerebral infarction, J. Cereb. Blood Flow Metab., 29, 34, 10.1038/jcbfm.2008.92 · DOI
  58. Tang, 2009, Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression, Circ. Res., 104, 1209, 10.1161/CIRCRESAHA.109.197723 · DOI · Paper page
  59. Terada, 2002, Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion, Nature, 416, 542, 10.1038/nature730 · DOI · Paper page
  60. Thomas, 1989, The leukocyte common antigen family, Annu. Rev. Immunol., 7, 339, 10.1146/annurev.iy.07.040189.002011 · DOI · Paper page
  61. Uemura, 2006, Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling, Circ. Res., 98, 1414, 10.1161/01.RES.0000225952.61196.39 · DOI · Paper page
  62. Wagers, 2002, Little evidence for developmental plasticity of adult hematopoietic stem cells, Science, 297, 2256, 10.1126/science.1074807 · DOI · Paper page
  63. Wang, 2014, Bone marrow mononuclear cell transplantation promotes therapeutic angiogenesis via upregulation of the VEGF-VEGFR2 signaling pathway in a rat model of vascular dementia, Behav. Brain Res., 265, 171, 10.1016/j.bbr.2014.02.033 · DOI
  64. Wang, 2013, Bone marrow mononuclear cells exert long-term neuroprotection in a rat model of ischemic stroke by promoting arteriogenesis and angiogenesis, Brain Behav. Immun., 34C, 56, 10.1016/j.bbi.2013.07.010 · DOI
  65. Wang, 2012, Roles of chemokine CXCL12 and its receptors in ischemic stroke, Curr. Drug Targets, 13, 166, 10.2174/138945012799201603 · DOI
  66. Widiapradja, 2014, Intravenous immunoglobulin (IVIg) provides protection against endothelial cell dysfunction and death in ischemic stroke, Exp. Transl. Stroke Med., 6, 7, 10.1186/2040-7378-6-7 · DOI
  67. Willing, 2003, Intravenous versus intrastriatal cord blood administration in a rodent model of stroke, J. Neurosci. Res., 73, 296, 10.1002/jnr.10659 · DOI · Paper page
  68. Yang, 2013, Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke, Stroke, 44, 3463, 10.1161/STROKEAHA.111.000821 · DOI
  69. Yang, 2011, Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke, J. Neurosci. Res., 89, 833, 10.1002/jnr.22614 · DOI

Metadata

Authors
Wang, J., Liu, X., Lu, H., Jiang, C., Cui, X., Yu, L., Fu, X., Li, Q., & Wang, J.
Venue
Brain, Behavior, and Immunity
Publisher
Elsevier BV
Published
2015-03
Volume
45
Pages
98-108
ISSN
0889-1591
Cited by
36
References
1
Language
en
Update notices
erratum (2021-01-01)
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • NSFC (81271284)
  • AHA (13GRNT15730001)
  • NIH (K01AG031926, R01AT007317, R01NS078026)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CXCR4+CD45− BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in mice. https://app.cochat.ai/papers/10.1016/j.bbi.2014.12.015
The paper
Wang, J., Liu, X., Lu, H., Jiang, C., Cui, X., Yu, L., Fu, X., Li, Q., & Wang, J. (2015). CXCR4+CD45− BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in mice. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2014.12.015

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.